US2014142188A1PendingUtilityA1
Prostaglandin compositions and methods for the treatment of vasospasm
Est. expiryApr 2, 2023(expired)· nominal 20-yr term from priority
A61K 47/10A61K 9/0014A61K 31/5575A61K 47/36A61P 9/14A61K 47/26A61P 43/00A61K 47/18A61P 7/02A61K 47/14A61P 9/10A61P 9/00A61K 31/557
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions and methods for the treatment of vasospasm are provided comprising applying an amount of a semi-solid vasoactive prostaglandin composition to the affected tissue. Also provided are methods of improving microcirculation in a replanted body part.
Claims
exact text as granted — not AI-modified1 - 64 . (canceled)
65 . A method of improving local microcirculation in a hand tissue comprising:
applying directly to a surface of the hand tissue of a subject needing improvement of local microcirculation a composition comprising: one or more of prostaglandin E1, a pharmaceutically acceptable salt of prostaglandin E1, and a C 1 to C 4 alkyl ester of prostaglandin E1 or a pharmaceutically acceptable salt thereof; a penetration enhancer selected from the group consisting of an alkyl-(N-substituted amino) ester elected from the group consisting of an alkyl-(N-substituted amino)alkanoate, an alkyl-2-(N,N-disubstituted amino)alkanoate, an (N-substituted amino)alkanol alkanoate, an (N,N-disubstituted amino)alkanol alkanoate, a pharmaceutically acceptable salt thereof, and a mixture thereof; a shear-thinning polymer thickener selected from the group consisting of a shearthinning polysaccharide gum and a shear-thinning polyacrylic acid polymer; a lipophilic component that is selected from the group consisting of an aliphatic C 1 to C 8 alcohol, an aliphatic C 8 to C 30 ester, a liquid polyol and a mixture thereof; water and a buffer system that provides a buffered pH.
66 . The method of claim 65 further comprising the step of applying the composition to the vascular extima of the blood vessels supplying the hand tissue.
67 . The method of claim 65 wherein the surface to which the composition is applied is the surface of skin.
68 . The method of claim 65 wherein the polysaccharide gum is a shear-thinning polysaccharide gum.
69 . The method of claim 65 wherein the tissue is of a subject needing treatment of vasospasm.
70 . The method of claim 68 wherein the shear-thinning polysaccharide gum is a galactomannan gum or a modified galactomannan gum.
71 . The method of claim 70 wherein the modified galactomannan gum is a modified guar gum.
72 . The method of claim 65 wherein the shear-thinning polymer thickener is a shear-thinning polyacrylic acid polymer.
73 . The method of claim 65 wherein the penetration enhancer is dodecyl 2-(N,N-dimethylamino)-propionate or a pharmaceutically acceptable salt thereof.
74 . The method of claim 65 wherein the lipophilic component comprises at least one aliphatic C 8 to C 30 ester.
75 . The method of claim 65 , wherein the buffered pH value for said composition is in the range of about 3 to about 7.4.
76 . The method of claim 65 , wherein the composition is applied by a transdermal patch.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.